To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy, safety and tolerability of vildagliptin
compared to voglibose in patients with type 2 diabetes. Please note this study is not being
conducted in the United States.